ONVO

Organovo Holdings Inc

A clinical-stage biotechnology company that 3D-prints living human tissues using "bioinks" made of real human cells, creating models that drug researchers use to test new medicines for liver disease and inflammatory bowel conditions. Founded in 2007 from research by Professor Gabor Forgacs at the University of Missouri, the company's name blends "organ" with the Latin "novo" (new). Its first commercial product, exVive3D Human Liver Tissue, launched in 2014.

Recent Activity

Show $

2020Q4

3 sells

ARK Autonomous Technology & Robotics ETFEXIT

-3.06M shares

ARK Autonomous Technology & Robotics ETFEXIT

-3.06M shares

ARK Genomic Revolution ETFEXIT

-7.62M shares

ARK Genomic Revolution ETFEXIT

-7.62M shares

ARK Innovation ETFEXIT

-16.92M shares

ARK Innovation ETFEXIT

-16.92M shares

2020Q3

1 buy3 sells

ARK Autonomous Technology & Robotics ETFADD

+1.21M shares(+65.1%)

ARK Autonomous Technology & Robotics ETFADD

+1.21M shares(+65.1%)

ARK Genomic Revolution ETFTRIM

-25.8K shares(-0.3%)

ARK Genomic Revolution ETFTRIM

-25.8K shares(-0.3%)

ARK Innovation ETFTRIM

-78.9K shares(-0.5%)

ARK Innovation ETFTRIM

-78.9K shares(-0.5%)

ARK InvestEXIT

-27.14M shares

ARK InvestEXIT

-27.14M shares

2020Q2

4 buys

ARK Autonomous Technology & Robotics ETFNEW

+1.86M shares

ARK Autonomous Technology & Robotics ETFNEW

+1.86M shares

ARK Genomic Revolution ETFNEW

+7.65M shares

ARK Genomic Revolution ETFNEW

+7.65M shares

ARK Innovation ETFNEW

+17.00M shares

ARK Innovation ETFNEW

+17.00M shares

ARK InvestADD

+4.23M shares(+18.4%)

ARK InvestADD

+4.23M shares(+18.4%)

2020Q1

1 buy

ARK InvestADD

+3.41M shares(+17.5%)

ARK InvestADD

+3.41M shares(+17.5%)

Loading more activity...